Highlights Sailong Pharmaceutical Group Co.,Ltd.

Equities

002898

CNE1000032S5

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-03 EDT			5-day change	1st Jan Change
9.18 ^CNY	-2.24%		-5.07%	-34.29%

04-19	Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
Sailong Pharma's Unit Gets Nod to Market Pregabalin	03-08	MT
Sailong Pharma Gets Registration Certificate for Pregabalin Capsules	03-04	MT
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Wu Gulin signed share transfer agreement to acquire Hunan Shenglong Real Estate Co., Ltd. from Zhuhai Sailong Pharmaceutical Co.,Ltd. for CNY 10.2 million.	21-05-17	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Proposes No Final Dividend for 2020	21-04-30	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-10	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Implementation of A Share Dividend for the Year 2019, Payable on 16 July 2020	20-07-08	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2019	20-05-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sailong Pharmaceutical Group Co.,Ltd.

Equities

002898

CNE1000032S5

Highlights

Filters